GWLL

GOLDENWELL BIOTECH INC by GOLDENWELL BIOTECH INC. (GWLL)

About GOLDENWELL BIOTECH INC by GOLDENWELL BIOTECH INC. (GWLL)

Goldenwell Biotech, Inc. is a development stage company, which engages in the research & development and industrialization of healthcare products, bio-pharmaceuticals and bio-engineering drugs, and food and cosmetics products. The firm plans to develop, manufacture and market five products: Bovine Cardiac Vascular Active Peptide, Double Proline AG-3D Active Collagen Peptide, Cartilage Peptide-Type II Collagen Peptide, DNA Repair, and Sugar Master. The company was founded on August 20, 2019 and is headquartered in Solon, OH.

Details

Daily high
--
Daily low
--
Price at open
--
52 Week High
$10.00
52 Week Low
$0.20
Market cap
297.0M
Dividend yield
0.00%
Volume
--
Avg. volume
36
P/E ratio
-2,307.69

GOLDENWELL BIOTECH INC by GOLDENWELL BIOTECH INC. News

Details

Daily high
--
Daily low
--
Price at open
--
52 Week High
$10.00
52 Week Low
$0.20
Market cap
297.0M
Dividend yield
0.00%
Volume
--
Avg. volume
36
P/E ratio
-2,307.69